931 - 940 of 8571 Results
Title
Year
-
OPENTitle: LRRK2 inhibition prevents endolysosomal deficits seen in human Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 134Issue #:Start Page: 104626End Page: 104626Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2019.104626Best OA location URL: https://doi.org/10.1016/j.nbd.2019.104626Citation Count: 88
- Estrogen-related receptor gamma regulates mitochondrial and synaptic genes and modulates vulnerability to synucleinopathy2022OPENTitle: Estrogen-related receptor gamma regulates mitochondrial and synaptic genes and modulates vulnerability to synucleinopathyJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00369-wBest OA location URL: https://www.nature.com/articles/s41531-022-00369-w.pdfCitation Count: 19
-
OPENTitle: Ceruloplasmin functional changes in Parkinson’s disease-cerebrospinal fluidJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-015-0055-2Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-015-0055-2Citation Count: 39
- Effects of long-term treatment with rotigotine transdermal system on dyskinesia in patients with early-stage Parkinson's disease2014RESTRICTEDTitle: Effects of long-term treatment with rotigotine transdermal system on dyskinesia in patients with early-stage Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 20Issue #: 12Start Page: 1345End Page: 1351Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.09.016Citation Count: 25
-
OPENTitle: Cerebellar Volume and Disease Staging in Parkinson's Disease: An ENIGMA‐PD StudyJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 12Start Page: 2269End Page: 2281Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29611Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29611Citation Count: 12
-
OPENTitle: RedOx regulation of LRRK2 kinase activity by active site cysteinesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00683-5Best OA location URL: https://www.nature.com/articles/s41531-024-00683-5.pdfCitation Count: 3
- Risk variants of the α-synuclein locus and REM sleep behavior disorder in Parkinson’s disease: a genetic association study2018OPENTitle: Risk variants of the α-synuclein locus and REM sleep behavior disorder in Parkinson’s disease: a genetic association studyJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 18Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-018-1023-6Best OA location URL: https://bmcneurol.biomedcentral.com/track/pdf/10.1186/s12883-018-1023-6Citation Count: 17
- The Michael J. Fox Foundation's quest for a cure for Parkinson's disease: an interview with Nicole Polinski2023OPENTitle: The Michael J. Fox Foundation's quest for a cure for Parkinson's disease: an interview with Nicole PolinskiJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol: 16Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1242/dmm.050605Best OA location URL: https://journals.biologists.com/dmm/article-pdf/16/12/dmm050605/3311458/dmm050605.pdfCitation Count: 0
-
OPENTitle: Plasma Glucosylsphingosine in GBA1 Mutation Carriers with and without Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 2Start Page: 416End Page: 421Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28846Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.28846Citation Count: 36
- Generation of two human induced pluripotent stem cell lines (iPSCs) with mutations of the α-synuclein (SNCA) gene associated with Parkinson’s disease; the A53T mutation (LCSBi003) and a triplication of the SNCA gene (LCSBi007)2021OPENTitle: Generation of two human induced pluripotent stem cell lines (iPSCs) with mutations of the α-synuclein (SNCA) gene associated with Parkinson’s disease; the A53T mutation (LCSBi003) and a triplication of the SNCA gene (LCSBi007)Journal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 57Issue #:Start Page: 102600End Page: 102600Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.scr.2021.102600Best OA location URL: https://doi.org/10.1016/j.scr.2021.102600Citation Count: 0